Your institution may have access to this item. Find your institution then sign in to continue.
Title
Immunotherapy: Low-dose IL-2 therapy expands human regulatory T cell populations.
Abstract
The article discusses the effect of low-dose Interleukin-2 (IL-2) therapy to human regulatory T cell populations of patients with graft-versus-host disease (GVHD), which references the study "Interleukin-2 and regulatory T cells in graft-versus-host disease," by J. Koreth and colleagues.